tradingkey.logo
搜尋

Eikon Therapeutics Ord Shs

EIKN
添加自選
12.540USD
+0.290+2.37%
收盤 07/02, 13:00美東報價延遲15分鐘
663.20M總市值
虧損本益比TTM

關於 Eikon Therapeutics Ord Shs 公司

Eikon Therapeutics Ord Shs簡介

公司代碼EIKN
公司名稱Eikon Therapeutics Inc
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)
員工數量384
證券類型Ordinary Share
年結日Feb 05
公司地址230 Harriet Tubman Way
城市MILLBRAE
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編94030
電話13026587581
網址https://eikontx.com/
公司代碼EIKN
上市日期Feb 05, 2026
CEOPerlmutter (Roger M)

Eikon Therapeutics Ord Shs公司高管

名稱
名稱/職務
職務
持股
持股變動
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--
Mr. Benjamin Thorner
Mr. Benjamin Thorner
Chief Business Officer, General Counsel
Chief Business Officer, General Counsel
--
--
Dr. Leon Chen, Ph.D.
Dr. Leon Chen, Ph.D.
Director
Director
--
--
Mr. Robert Huffines
Mr. Robert Huffines
Independent Director
Independent Director
--
--
Mr. David Meline
Mr. David Meline
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. Roger M. Perlmutter, M.D., Ph.D.
Dr. Roger M. Perlmutter, M.D., Ph.D.
Chairman of the Board, Chief Executive Officer, Director
Chairman of the Board, Chief Executive Officer, Director
1.48M
--
Mr. Kenneth C. Frazier
Mr. Kenneth C. Frazier
Independent Director
Independent Director
111.11K
+100.00%
,
,
--
--
Dr. Alfred Bowie, Ph.D.
Dr. Alfred Bowie, Ph.D.
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Roy D. Baynes, M.D., Ph.D.
Dr. Roy D. Baynes, M.D., Ph.D.
Executive Vice President, Chief Medical Officer
Executive Vice President, Chief Medical Officer
--
-100.00%
Mr. Michael A. Klobuchar
Mr. Michael A. Klobuchar
Chief Operating Officer
Chief Operating Officer
--
--

常見問題

Eikon Therapeutics Ord Shs的前五大股東是誰?

Eikon Therapeutics Ord Shs的前五大股東如下:Dr. Roger M. Perlmutter, M.D., Ph.D.